Mounjaro®
Dual-agonist support that helps curb appetite, hunger, and cravings to drive substantial, sustained weight loss.
- ~22.5% average body weight loss
- Significant weight reduction
- Improves blood sugar levels
- Clinically proven weight loss

Testogel is a prescription testosterone replacement therapy used to treat male hypogonadism, a condition where the body cannot produce adequate testosterone. Understanding the reasons for using Testogel is essential for men experiencing symptoms of low testosterone. This gel-based treatment is prescribed only after blood tests confirm testosterone deficiency alongside relevant clinical symptoms. Testogel works by delivering testosterone through the skin, helping to restore hormone levels and alleviate symptoms affecting sexual function, physical health, and psychological wellbeing. This article explores the medical indications, symptoms treated, safety considerations, and proper use of Testogel in the UK.
Summary: Testogel is prescribed for confirmed male hypogonadism, where the body fails to produce sufficient testosterone, causing symptoms affecting sexual function, physical health, and mood.
Testogel is a transdermal testosterone replacement therapy (TRT) available on prescription in the UK for men with confirmed testosterone deficiency. It contains testosterone as the active ingredient, formulated as a clear or slightly opalescent gel that is applied directly to the skin.
The gel works through transdermal absorption, allowing testosterone to pass through the skin and into the bloodstream gradually over 24 hours. Once absorbed, testosterone is distributed throughout the body where it binds to androgen receptors in various tissues, including muscle, bone, and the central nervous system. This provides relatively stable blood levels throughout the day.
Testosterone is the primary male sex hormone (androgen) responsible for developing and maintaining male characteristics. In adult men, it plays crucial roles in:
Maintaining muscle mass and bone density
Regulating libido and sexual function
Supporting mood and cognitive function
Influencing fat distribution and red blood cell production
Testogel is available in two formulations in the UK: 1% sachets (50 mg per 5 g sachet) and 16.2 mg/g pump. Each has specific application instructions and dosing recommendations. The gel formulation offers several advantages over other testosterone delivery methods. Unlike intramuscular injections, which can cause fluctuating testosterone levels, Testogel can provide more consistent hormone levels. It is also non-invasive and can be self-administered at home.
Important safety notes: The gel is flammable until dry, so avoid smoking or naked flames during application. There are also specific precautions regarding skin-to-skin contact with others, particularly women and children, to prevent unintended testosterone transfer.
Testogel is prescribed specifically for male hypogonadism, a clinical condition characterised by the body's inability to produce adequate amounts of testosterone. This diagnosis must be confirmed through blood tests showing consistently low testosterone levels alongside relevant clinical symptoms.
Diagnosis requires at least two early-morning blood samples (ideally taken between 8-10am when testosterone is naturally highest), preferably when fasting and not during acute illness. Laboratory reference ranges vary, and borderline results may require additional testing of sex hormone binding globulin (SHBG) and calculated free testosterone.
Primary hypogonadism occurs when the testes themselves fail to produce sufficient testosterone due to:
Genetic conditions such as Klinefelter syndrome
Testicular injury or infection (orchitis)
Chemotherapy or radiotherapy affecting the testes
Undescended testes (cryptorchidism) that were not corrected in childhood
Secondary hypogonadism results from problems with the hypothalamus or pituitary gland, which normally signal the testes to produce testosterone. Causes include:
Pituitary tumours or damage from surgery/radiotherapy
Kallmann syndrome (a genetic condition affecting hormone production)
Chronic illnesses affecting the hypothalamic-pituitary axis
Certain medications, particularly opioids and corticosteroids
According to NICE Clinical Knowledge Summaries, testosterone replacement should only be initiated after thorough investigation to identify the underlying cause of hypogonadism and exclude other treatable conditions. Blood tests should include not only testosterone levels but also luteinising hormone (LH), follicle-stimulating hormone (FSH), and prolactin to distinguish between primary and secondary causes. Secondary hypogonadism typically requires referral to an endocrinologist for further investigation, including possible pituitary imaging.
It is important to note that Testogel is not licensed for treating age-related decline in testosterone (sometimes called 'andropause' or late-onset hypogonadism) unless there is a clear pathological cause. The normal age-related decline in testosterone does not automatically warrant treatment, and lifestyle modifications should be considered first. Testogel is also not appropriate for enhancing athletic performance or bodybuilding, and such use is both illegal and potentially harmful.
Men with clinically significant testosterone deficiency may experience a range of symptoms affecting physical, sexual, and psychological wellbeing. Testogel aims to alleviate these symptoms when they are directly attributable to confirmed low testosterone levels.
Sexual symptoms are often the most noticeable and include:
Reduced libido (sex drive)
Erectile dysfunction or difficulty maintaining erections
Decreased spontaneous erections, particularly morning erections
Important note: Testosterone replacement therapy (TRT) typically reduces sperm production and should not be used to treat fertility problems. Men wishing to father children should discuss this with their doctor, as alternative treatments may be more appropriate.
Physical symptoms that may improve with testosterone replacement include:
Loss of muscle mass and strength
Increased body fat, particularly around the abdomen
Reduced bone density (osteoporosis or osteopenia), increasing fracture risk
Decreased body hair growth
Persistent fatigue and reduced physical stamina
Hot flushes or sweating episodes
Note: Gynaecomastia (breast tissue enlargement) may have multiple causes and should be evaluated separately. Testosterone therapy can sometimes worsen this condition rather than improve it.
Psychological and cognitive symptoms associated with low testosterone include:
Low mood or depressive symptoms
Irritability and mood swings
Poor concentration and memory difficulties
Reduced motivation and self-confidence
Sleep disturbances
It is crucial to understand that these symptoms are non-specific and can result from numerous other medical conditions, including thyroid disorders, diabetes, depression, sleep apnoea, and cardiovascular disease. Therefore, a comprehensive medical assessment is essential before attributing symptoms solely to testosterone deficiency.
Response to Testogel varies between individuals. Some men notice improvements in energy, mood, and libido within 3–6 weeks, whilst changes in muscle mass, bone density, and body composition typically require 3–6 months of consistent treatment. If symptoms do not improve after an adequate trial period (usually 3–6 months), the diagnosis should be reconsidered, and alternative causes investigated.
Testogel has several absolute and relative contraindications that must be carefully considered before initiating treatment. Healthcare professionals will assess individual risk factors to determine suitability.
Absolute contraindications (Testogel must not be used) include:
Known or suspected prostate cancer or breast cancer (current or previous)
Severe hepatic or renal insufficiency
Severe heart failure (NYHA Class IV)
Hypersensitivity to testosterone or any gel excipients
Relative contraindications (requiring careful assessment and monitoring) include:
Elevated prostate-specific antigen (PSA) levels requiring investigation
Benign prostatic hyperplasia (BPH) with significant urinary symptoms
Polycythaemia (elevated red blood cell count with haematocrit >0.54)
Sleep apnoea, which may worsen with testosterone therapy
Cardiovascular disease, including previous heart attack or stroke
Hypertension (high blood pressure)
Epilepsy or migraine, as testosterone may affect seizure threshold
Kidney or liver disease (mild to moderate)
History of blood clots (thromboembolism) or thrombophilia
Special populations requiring caution:
Testogel is not indicated for use in women or children/adolescents and should never be used during pregnancy or breastfeeding due to potential virilisation of female foetuses and infants.
Elderly men require particularly careful assessment, as they have higher rates of prostate disease and cardiovascular conditions. The MHRA advises regular monitoring of haematocrit in all patients, as testosterone can stimulate red blood cell production, potentially increasing cardiovascular risk. Treatment should be withheld or stopped if haematocrit exceeds 0.54.
Before prescribing Testogel, doctors should perform:
Digital rectal examination and PSA testing to screen for prostate abnormalities
Full blood count to check for polycythaemia
Liver function tests
Lipid profile and cardiovascular risk assessment
Patients should inform their healthcare provider of all medications they are taking, as testosterone can interact with anticoagulants (such as warfarin), antidiabetic drugs, and corticosteroids.
Proper application technique is essential for optimal absorption and to prevent accidental transfer to others. Testogel should be applied once daily, preferably at the same time each morning, to clean, dry, intact skin.
Application instructions vary by formulation:
For Testogel 1% (50 mg sachets):
Apply to shoulders, upper arms, or abdomen
Starting dose is typically one 5 g sachet (50 mg) daily
For Testogel 16.2 mg/g (pump):
Apply only to shoulders and upper arms (not abdomen)
Starting dose is typically 2 pump actuations (40.5 mg) daily
For both formulations:
Spread the gel thinly over the application area
Wash hands thoroughly with soap and water immediately after application
Allow the gel to dry completely before dressing (3-5 minutes)
Cover the application site with clothing once dry
Follow the specific washing/showering instructions in your patient information leaflet
Keep away from fire, flames or smoking until the gel has dried (it is flammable)
Preventing transfer to others is critically important, as testosterone exposure can cause serious adverse effects in women and children, including virilisation (development of male characteristics). To minimise risk:
Avoid skin-to-skin contact with others at the application site
Wash the application area thoroughly before any situation involving close physical contact
Ensure children do not touch the application site
If someone else contacts the gel, they should wash the area immediately with soap and water
Wash any clothing or bedding that may have come into contact with the gel
Monitoring and follow-up:
Regular monitoring is essential to ensure treatment effectiveness and safety. Your GP or endocrinologist will typically arrange:
Testosterone level checks at 3 months, then 6–12 monthly (aiming for mid-normal range)
PSA testing and prostate examination annually (for men over 40 or at higher risk)
Full blood count to monitor haematocrit every 3–6 months initially, then annually
Treatment should be paused or stopped if haematocrit exceeds 0.54
Liver function tests periodically
Bone density scans if osteoporosis was present initially
When to seek medical advice:
Contact your GP promptly if you experience:
Difficulty urinating or changes in urinary flow
Breast lumps or tenderness
Prolonged or painful erections (priapism)
Ankle swelling or unexplained weight gain
Mood changes, aggression, or depression
Signs of blood clots (leg pain, swelling, chest pain, breathlessness)
Missed doses: If you forget a dose, apply it as soon as you remember on the same day. If it is nearly time for the next dose, skip the missed dose and continue as normal. Do not apply a double dose.
Testogel is a long-term treatment for a chronic condition. Do not stop using it without consulting your doctor, as symptoms may return. Regular review ensures that treatment remains appropriate and beneficial for your individual circumstances.
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk.
Testogel is not licensed for treating normal age-related testosterone decline unless there is a clear pathological cause of hypogonadism confirmed by blood tests. Lifestyle modifications should be considered first for age-related changes.
Some men notice improvements in energy, mood, and libido within 3–6 weeks, whilst changes in muscle mass, bone density, and body composition typically require 3–6 months of consistent treatment.
Testogel must not be used by men with known or suspected prostate or breast cancer, severe heart failure, severe liver or kidney disease, or hypersensitivity to testosterone. It is also not indicated for women, children, or during pregnancy.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript